Format

Send to

Choose Destination
See comment in PubMed Commons below
Pharmacotherapy. 1994 Nov-Dec;14(6):671-7.

Prolonged, but not diminished, zidovudine absorption induced by a high-fat breakfast.

Author information

  • 1Department of Pharmacy Practice, State University of New York at Buffalo.

Abstract

STUDY OBJECTIVE:

To determine the effect of a high-fat breakfast on single-dose, zidovudine (ZDV) pharmacokinetics.

DESIGN:

Open-label, randomized, crossover study.

PATIENTS:

Eighteen asymptomatic subjects (12 men, 6 women) infected with the human immunodeficiency virus (mean CD4 cell counts of 512 +/- 178/mm3).

INTERVENTIONS:

Subjects received single 100-mg oral doses of ZDV as follows: after an 8-hour fast (treatment A), with a high-fat breakfast (treatment B), and 3 hours after a high-fat breakfast (treatment C).

MEASUREMENTS AND MAIN RESULTS:

The high-fat breakfast significantly reduced the mean (coefficient of variation) maximum plasma concentration (Cmax) from 806 (55%) ng/ml with treatment A to 341 (47%) and 424 (42%) ng/ml with treatments B and C, respectively. The time to Cmax was significantly prolonged from 0.68 (30%) hours with treatment A to 1.7 (54%) and 1.3 (42%) hours with treatments B and C, respectively. Area under the plasma ZDV concentration-time curve (AUC) was not statistically different across the study treatments. Men had significantly lower (35%) renal clearances of both ZDV and its glucuronide metabolite than women.

CONCLUSIONS:

When ZDV was given either with or 3 hours after a high-fat breakfast, its absorption was prolonged and Cmax was reduced relative to fasting. However, systemic exposure, as indicated by AUC, was unchanged.

PMID:
7885970
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Write to the Help Desk